SOPHiA GENETICS Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
488
- Stock Symbol
-
SOPH
- Investments
-
1
- Share Price
-
$3.02
- (As of Friday Closing)
SOPHiA GENETICS General Information
Description
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Contact Information
Website
www.sophiagenetics.comCorporate Office
- La Pièce 12
- 1180 Rolle
- Switzerland
Corporate Office
- La Pièce 12
- 1180 Rolle
- Switzerland
SOPHiA GENETICS Stock Performance
As of 21-Mar-2025, SOPHiA GENETICS’s stock price is $3.02. Its current market cap is $202M with 66.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.02 | $3.00 | $2.70 - $6.28 | $202M | 66.8M | 78.4K | -$0.95 |
SOPHiA GENETICS Financials Summary
As of 31-Dec-2024, SOPHiA GENETICS has a trailing 12-month revenue of $65.2M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 139,852 | 139,852 | 191,873 | (40,724) |
| Revenue | 65,173 | 65,173 | 62,371 | 47,560 |
| EBITDA | (54,123) | (54,123) | (74,118) | (82,699) |
| Net Income | (62,493) | (62,493) | (78,981) | (87,449) |
| Total Assets | 155,309 | 155,309 | 206,156 | 243,838 |
| Total Debt | 30,030 | 30,030 | 18,601 | 16,743 |
SOPHiA GENETICS Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SOPHiA GENETICS Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
SOPHiA GENETICS Comparisons
Industry
Financing
Details
SOPHiA GENETICS Competitors (17)
One of SOPHiA GENETICS’s 17 competitors is Velsera, a Private Equity-Backed company based in Charlestown, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Velsera | Private Equity-Backed | Charlestown, MA | ||||
| DNAnexus | Venture Capital-Backed | Mountain View, CA | ||||
| Flatiron | Formerly VC-backed | New York, NY | ||||
| Benchling | Venture Capital-Backed | San Francisco, CA | ||||
| Partek | Corporate Backed or Acquired | Chesterfield, MO |
SOPHiA GENETICS Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SOPHiA GENETICS Patents
SOPHiA GENETICS Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240387046-A1 | Method for tumor fraction estimation | Pending | 19-May-2023 | ||
| FR-3143804-A1 | Method for taking combined hyperspectral and panchromatic moving photographs using a spatial imager | Pending | 19-Dec-2022 | ||
| EP-4307315-A1 | Machine learning predictive models of treatment response | Inactive | 11-Jul-2022 | ||
| EP-4287142-A1 | Deep learning models of radiomics features extraction | Inactive | 03-Jun-2022 | ||
| EP-4287212-A1 | Machine learning predictive models of treatment response | Inactive | 30-May-2022 | G16H50/50 |
SOPHiA GENETICS Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SOPHiA GENETICS Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SOPHiA GENETICS Acquisitions (1)
SOPHiA GENETICS’s most recent deal was a Merger/Acquisition with Interactive Biosoftware. The deal was made on 16-Jun-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Interactive Biosoftware | 16-Jun-2018 | Merger/Acquisition | Biotechnology |
SOPHiA GENETICS FAQs
-
When was SOPHiA GENETICS founded?
SOPHiA GENETICS was founded in 2011.
-
Where is SOPHiA GENETICS headquartered?
SOPHiA GENETICS is headquartered in Rolle, Switzerland.
-
What is the size of SOPHiA GENETICS?
SOPHiA GENETICS has 488 total employees.
-
What industry is SOPHiA GENETICS in?
SOPHiA GENETICS’s primary industry is Other Healthcare Technology Systems.
-
Is SOPHiA GENETICS a private or public company?
SOPHiA GENETICS is a Public company.
-
What is SOPHiA GENETICS’s stock symbol?
The ticker symbol for SOPHiA GENETICS is SOPH.
-
What is the current stock price of SOPHiA GENETICS?
As of 21-Mar-2025 the stock price of SOPHiA GENETICS is $3.02.
-
What is the current market cap of SOPHiA GENETICS?
The current market capitalization of SOPHiA GENETICS is $202M.
-
What is SOPHiA GENETICS’s current revenue?
The trailing twelve month revenue for SOPHiA GENETICS is $65.2M.
-
Who are SOPHiA GENETICS’s competitors?
Velsera, DNAnexus, Flatiron, Benchling, and Partek are some of the 17 competitors of SOPHiA GENETICS.
-
What is SOPHiA GENETICS’s annual earnings per share (EPS)?
SOPHiA GENETICS’s EPS for 12 months was -$0.95.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
